Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Heparin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 80238
Tytuł:
Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Autorzy:
Olson G; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Jeske W; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Iqbal O; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Krupa E; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Farooqui A; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Siddiqui F; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.; Program in Health Sciences, 16728UCAM - Universidad Católica San Antonio de Murcia, Murcia, Spain.
Hoppensteadt D; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Kouta A; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Fareed J; Cardiovascular Research Institute, Section of Hemostasis and Thrombosis, 25815Loyola University Medical Center, Maywood, IL, USA.
Pokaż więcej
Źródło:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2023 Jan-Dec; Vol. 29, pp. 10760296231163251.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/pharmacology
Biological Products*
Animals ; Sheep ; Cattle ; Swine ; Anticoagulants/pharmacology ; Heparin, Low-Molecular-Weight/pharmacology ; Protamines
Czasopismo naukowe
Szczegóły
Tytuł:
Randomized controlled trials of low molecular weight heparin in non-mild acute pancreatitis: A systemic review and meta-analysis.
Autorzy:
He K; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Zhang Y; Medical Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Song K; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Fan Z; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Gong L; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Shu H; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. Electronic address: .
Wu D; Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Clinical Epidemiology Unit, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China. Electronic address: .
Pokaż więcej
Źródło:
Thrombosis research [Thromb Res] 2023 Jan; Vol. 221, pp. 26-29. Date of Electronic Publication: 2022 Nov 18.
Typ publikacji:
Letter; Meta-Analysis; Systematic Review
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Pancreatitis*/drug therapy
Humans ; Acute Disease ; Anticoagulants/therapeutic use ; Heparin ; Randomized Controlled Trials as Topic
Raport
Szczegóły
Tytuł:
Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?
Autorzy:
Parvizi J; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
DeMik DE; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
Hozack WJ; Rothman Orthopaedic Institute, Philadelphia, Pennsylvania.
Dunbar MJ; Dalhousie University, Halifax, Nova Scotia, Canada.
Mont MA; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.
Lachiewicz PF; Duke University, Durham, North Carolina.
Pokaż więcej
Źródło:
The Journal of arthroplasty [J Arthroplasty] 2023 Jan; Vol. 38 (1), pp. 1-2. Date of Electronic Publication: 2022 Nov 06.
Typ publikacji:
Editorial
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Thromboembolism*/etiology
Thromboembolism*/prevention & control
Humans ; Aspirin/therapeutic use ; Anticoagulants/therapeutic use ; Heparin
Opinia redakcyjna
Szczegóły
Tytuł:
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update.
Autorzy:
Vitiello A; Pharmaceutical Department, Usl Umbria 1, XIV Settembre Street, 06132, Perugia, Italy.
Ferrara F; Pharmaceutical Department, Asl Napoli 3 SUD, Dell'Amicizia Street, 80035, Naples, Nola, Italy. .
Pokaż więcej
Źródło:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Apr; Vol. 37 (2), pp. 277-281. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Heparin, Low-Molecular-Weight*/pharmacology
Heparin, Low-Molecular-Weight*/therapeutic use
COVID-19*
Animals ; Heparin/adverse effects ; Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Heparin Rebound: An In-Depth Review.
Autorzy:
Stone ME; Icahn School of Medicine at Mount Sinai, New York, NY.
Vespe MW; Icahn School of Medicine at Mount Sinai, New York, NY.
Pokaż więcej
Źródło:
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2023 Apr; Vol. 37 (4), pp. 601-612. Date of Electronic Publication: 2022 Dec 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heparin*
Protamines*
Humans ; Blood Coagulation Tests ; Postoperative Hemorrhage ; Heparin Antagonists ; Cardiopulmonary Bypass ; Anticoagulants
Czasopismo naukowe
Szczegóły
Tytuł:
Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase.
Autorzy:
Yu Y; College of Pharmaceutical Science & Collaborative Innovation Center for Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment & Utilization of Zhejiang Province, Zhejiang University of Technology, 310014 Hangzhou, People's Republic of China.
Fu L; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
He P; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Xia K; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Varghese S; Department of Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Dordick J; Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Wang H; College of Pharmaceutical Science & Collaborative Innovation Center for Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment & Utilization of Zhejiang Province, Zhejiang University of Technology, 310014 Hangzhou, People's Republic of China. Electronic address: .
Zhang F; Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. Electronic address: .
Linhardt RJ; Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA; Department of Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate polymers [Carbohydr Polym] 2022 Nov 01; Vol. 295, pp. 119825. Date of Electronic Publication: 2022 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Glucuronidase*
Heparin, Low-Molecular-Weight*/chemistry
Animals ; Anticoagulants/chemistry ; Anticoagulants/pharmacology ; Disaccharides ; Heparin/chemistry ; Heparin Lyase ; Molecular Weight ; Uronic Acids
Czasopismo naukowe
Szczegóły
Tytuł:
Heparin: An old drug for new clinical applications.
Autorzy:
Wang P; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China; Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266200, China.
Chi L; Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266200, China.
Zhang Z; College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
Zhao H; Department of Ophthalmology and Visual Science, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai 200031, China.
Zhang F; Center for Biotechnology & Interdisciplinary Studies, Department of Chemistry & Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Linhardt RJ; Center for Biotechnology & Interdisciplinary Studies, Department of Chemistry & Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate polymers [Carbohydr Polym] 2022 Nov 01; Vol. 295, pp. 119818. Date of Electronic Publication: 2022 Jul 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heparin*/chemistry
Heparin*/pharmacology
Heparin*/therapeutic use
COVID-19 Drug Treatment*
Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Anticoagulants/chemistry ; Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Heparin, Low-Molecular-Weight/chemistry ; Heparin, Low-Molecular-Weight/pharmacology ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans
Czasopismo naukowe
Szczegóły
Tytuł:
How often are parenteral anticoagulants administered by parents?
Autorzy:
Favaloro EJ; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.; School of Dentistry and Medical Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia.; School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.
Pasalic L; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.; Westmead Clinical School, University of Sydney, Westmead, New South Wales, Australia.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Dec; Vol. 20 (12), pp. 2746-2750. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Anticoagulants*/adverse effects
Heparin, Low-Molecular-Weight*
Humans ; Heparin/adverse effects ; Infusions, Parenteral ; Parents
Raport
Szczegóły
Tytuł:
Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is it? Response to an Editorial.
Autorzy:
Harris IA; School of Clinical Medicine, UNSW Medicine & Health, South West Sydney Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia; Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; Institute of Musculoskeletal Health, School of Public Health, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia.
Sidhu VS; School of Clinical Medicine, UNSW Medicine & Health, South West Sydney Clinical School, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia; Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research.
Buchbinder R; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology, Cabrini Health, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
The Journal of arthroplasty [J Arthroplasty] 2023 Apr; Vol. 38 (4), pp. e7-e8.
Typ publikacji:
Letter
MeSH Terms:
Heparin, Low-Molecular-Weight*
Thromboembolism*/prevention & control
Humans ; Aspirin ; Anticoagulants ; Heparin
Opinia redakcyjna
Szczegóły
Tytuł:
Strategies for sustained release of heparin: A review.
Autorzy:
Yang X; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China.
Wang Q; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China.
Zhang A; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China.
Shao X; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China.
Liu T; NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
Tang B; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China. Electronic address: .
Fang G; School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province, 226001, China. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate polymers [Carbohydr Polym] 2022 Oct 15; Vol. 294, pp. 119793. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heparin*/therapeutic use
Thrombosis*
Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Delayed-Action Preparations ; Heparin, Low-Molecular-Weight/pharmacology ; Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis.
Autorzy:
Zhang W; Department of Hepatobiliary and Pancreatic Surgery, Qinghai University Affiliated Hospital, Xining, Qinghai Province, China.
Wei X; Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, Qinghai Province, China.
Yang S; Organ Transplant Center and Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, China.
Du C; Department of Cardiology, The First People's Hospital of Guangyuan, Guangyuan, Sichuan Province, China.
Hu B; Department of Emergency, Pizhou Hospital of Traditional Chinese Medicine, Pizhou, Jiangsu Province, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2022 Nov 18; Vol. 101 (46), pp. e31948.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Venous Thromboembolism*/epidemiology
Humans ; Heparin/therapeutic use ; Treatment Outcome ; Anticoagulants/therapeutic use ; Hemorrhage/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin.
Autorzy:
Zhang G; Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, PR China. .
Yang K; Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, PR China. .
Wang L; Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, PR China. .
Cheng Y; Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, PR China. .
Liu C; Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, PR China. .; National Glycoengineering Research Center, Shandong University, Jinan 250012, Shandong, PR China.
Pokaż więcej
Źródło:
Organic & biomolecular chemistry [Org Biomol Chem] 2022 Nov 02; Vol. 20 (42), pp. 8323-8330. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anticoagulants*/pharmacology
Anticoagulants*/chemistry
Heparin, Low-Molecular-Weight*
Heparin/chemistry ; Heparitin Sulfate/chemistry ; Oligosaccharides/chemistry
Czasopismo naukowe
Szczegóły
Tytuł:
ISTH guidelines for antithrombotic treatment in COVID-19.
Autorzy:
Schulman S; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.; Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Sholzberg M; Departments of Medicine, and Laboratory Medicine and Pathobiology, St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.
Spyropoulos AC; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
Zarychanski R; Sections of Hematology/Oncology and Critical Care, University of Manitoba, Winnipeg, Manitoba, Canada.
Resnick HE; Resnick, Chodorow & Associates, Silver Spring, Maryland, USA.
Bradbury CA; Faculty of Health Sciences, University of Bristol, Bristol, UK.
Broxmeyer L
Connors JM; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Falanga A; Department of Transfusion Medicine and Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy.; University of Milan Bicocca, Monza, Italy.
Iba T; Department of Emergency and Disaster Medicine, Juntendo University, Tokyo, Japan.
Kaatz S; Division of Hospital Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Levy JH; Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Durham, North Carolina, USA.
Middeldorp S; Department of Internal Medicine and Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Minichiello T; Division of Hematology, San Francisco VA Medical Center, University of California, San Francisco, San Francisco, California, USA.
Ramacciotti E; Science Valley Research Institute, São Paulo, Brazil.; Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil.
Samama CM; Department of Anaesthesia, Centre-Université de Paris-Cochin Hospital, Intensive Care and Perioperative Medicine GHU AP-HP, Paris, France.
Thachil J; Department of Haematology, Manchester University Hospitals, Manchester, UK.
Pokaż więcej
Corporate Authors:
International Society on Thrombosis and Haemostasis
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Oct; Vol. 20 (10), pp. 2214-2225. Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Heparin, Low-Molecular-Weight*
Aftercare ; Anticoagulants/adverse effects ; Fibrinolytic Agents/adverse effects ; Heparin/adverse effects ; Humans ; Patient Discharge ; Platelet Aggregation Inhibitors/adverse effects ; Rivaroxaban
Czasopismo naukowe
Szczegóły
Tytuł:
Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery.
Autorzy:
Iliuta L; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy 'Carol Davila', 050474 Bucharest, Romania.; Cardioclass Clinic for Cardiovascular Disease, 031125 Bucharest, Romania.
Andronesi A; Nephrology Department, University of Medicine and Pharmacy 'Carol Davila', 050474 Bucharest, Romania.; Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Camburu G; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy 'Carol Davila', 050474 Bucharest, Romania.
Rac-Albu M; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy 'Carol Davila', 050474 Bucharest, Romania.; Cardioclass Clinic for Cardiovascular Disease, 031125 Bucharest, Romania.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Aug 18; Vol. 58 (8). Date of Electronic Publication: 2022 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Enoxaparin*/therapeutic use
Heparin*/therapeutic use
Anticoagulants ; Heart Valves ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Quality of Life
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-centre cohort study using the French national health data system.
Autorzy:
Bouget J; Université de Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, 35043, Rennes, France. .; Emergency Department, Rennes University Hospital, 35033, Rennes, France. .
Balusson F; Université de Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, 35043, Rennes, France.
Kerbrat S; Université de Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, 35043, Rennes, France.
Roy PM; Emergency Department, Institut MITOVASC, Centre Hospitalier Universitaire, Université d'Angers, 49033, Angers, France.; F-CRIN INNOVTE, Saint-Étienne, France.
Viglino D; Emergency Department, Grenoble-Alpes University Hospital, 38043, Grenoble, France.
Lacut K; Université de Bretagne Loire, Université de Brest, INSERM CIC 1412, CHRU de Brest, CIC 1412, 29200, Brest, France.
Pavageau L; Emergency Department, University Hospital, 44093, Nantes, France.
Oger E; Université de Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES, 35043, Rennes, France.
Pokaż więcej
Źródło:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Jul; Vol. 78 (7), pp. 1137-1144. Date of Electronic Publication: 2022 Apr 06.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Heparin, Low-Molecular-Weight*/adverse effects
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/prevention & control
Adult ; Anticoagulants/adverse effects ; Cohort Studies ; Enoxaparin/therapeutic use ; Fondaparinux/therapeutic use ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Heparin/therapeutic use ; Humans ; Incidence ; Polysaccharides/therapeutic use ; Prospective Studies ; Tinzaparin/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.
Autorzy:
Billoir P; Normandie Univ, UNIROUEN, INSERM U1096, Rouen University Hospital, Vascular Hemostasis Unit, F 76000 Rouen, France.
Elie T; Department of Anesthesiology and Critical Care, Rouen University Hospital, F 76000 Rouen, France.
Levy JH; Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Durham, NC 27710, USA.
Besnier E; Department of Anesthesiology and Critical Care, Rouen University Hospital, Normandie Univ, UNIROUEN, INSERM U1096, F 76000 Rouen, France.
Dureuil B; Department of Anesthesiology and Critical Care, Rouen University Hospital, F 76000 Rouen, France.
Veber B; Department of Anesthesiology and Critical Care, Rouen University Hospital, F 76000 Rouen, France.
Le Cam-Duchez V; Normandie Univ, UNIROUEN, INSERM U1096, Rouen University Hospital, Vascular Hemostasis Unit, F 76000 Rouen, France.
Clavier T; Department of Anesthesiology and Critical Care, Rouen University Hospital, F 76000 Rouen, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 23; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 23.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Heparin*/pharmacology
Thrombin*
Adult ; Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Biomarkers ; C-Reactive Protein ; Drug Monitoring ; Factor Xa Inhibitors/pharmacology ; Factor Xa Inhibitors/therapeutic use ; Heparin, Low-Molecular-Weight ; Humans ; Intensive Care Units ; Partial Thromboplastin Time ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sequencing analysis of heparin reducing terminals with orthogonal chromatographic approaches.
Autorzy:
Zhu W; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Chen L; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Yan N; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Yi L; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Sun Y; The fourth people's Hospital of Jinan City, Shandong 250031, China.
Ouyang Y; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Liu D; The fourth people's Hospital of Jinan City, Shandong 250031, China.
Zhang Z; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China. Electronic address: z_.
Pokaż więcej
Źródło:
Journal of chromatography. A [J Chromatogr A] 2022 Aug 16; Vol. 1677, pp. 463318. Date of Electronic Publication: 2022 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Disaccharides*/chemistry
Heparin*/chemistry
Heparin Lyase ; Oligosaccharides/chemistry ; Transferases
Czasopismo naukowe
Szczegóły
Tytuł:
Glycan Mapping of Low-Molecular-Weight Heparin Using Mass Spectral Correction Based on Chromatography Fitting with "Glycomapping" Software.
Autorzy:
Yan N; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Song F; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Ouyang Y; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Li D; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Tian H; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Yi L; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Linhardt RJ; Departments of Chemistry and Chemical Biology, Biology, Chemical and Biological Engineering, and Biomedical Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 8th Street, Troy, New York 12180, United States.
Zhang Z; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China.
Pokaż więcej
Źródło:
Analytical chemistry [Anal Chem] 2022 Sep 27; Vol. 94 (38), pp. 13000-13009. Date of Electronic Publication: 2022 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Enoxaparin*/chemistry
Heparin, Low-Molecular-Weight*/analysis
Animals ; Anticoagulants ; Chromatography, Liquid ; Dalteparin ; Heparin/chemistry ; Nadroparin/chemistry ; Software
Czasopismo naukowe
Szczegóły
Tytuł:
Delayed Cranial Decompression Rates After Initiation of Unfractionated Heparin versus Low-Molecular-Weight Heparin in Traumatic Brain Injury.
Autorzy:
Maragkos GA; Department of Neurosurgery, Mount Sinai Morningside Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cho LD; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Legome E; Department of Emergency Medicine, Mount Sinai West and Mount Sinai Morningside Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Wedderburn R; Department of Surgery, Mount Sinai Morningside Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Margetis K; Department of Neurosurgery, Mount Sinai Morningside Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: .
Pokaż więcej
Źródło:
World neurosurgery [World Neurosurg] 2022 Aug; Vol. 164, pp. e1251-e1261. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Injuries, Traumatic*/chemically induced
Brain Injuries, Traumatic*/complications
Brain Injuries, Traumatic*/surgery
Heparin, Low-Molecular-Weight*/therapeutic use
Anticoagulants/therapeutic use ; Antidotes ; Decompression ; Heparin/therapeutic use ; Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy of Low Molecular Weight Heparin in Preventing Perinatal Venous Thrombosis: A Meta-Analysis.
Autorzy:
Huang Y; Department of Obstetrics, Hainan Women and Children's Medical Center, Haikou 570216, China.
Li F; Department of Obstetrics and Gynecology, Chengmai County People's Hospital, Chengmai 571900, China.
Li C; Department of Obstetrics, Hainan Women and Children's Medical Center, Haikou 570216, China.
Liao X; Department of Pharmacy, Hainan Women and Children's Medical Center, Haikou 570216, China.
Pokaż więcej
Źródło:
Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Jul 26; Vol. 2022, pp. 1248577. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Venous Thrombosis*/drug therapy
Venous Thrombosis*/epidemiology
Venous Thrombosis*/prevention & control
Anticoagulants/therapeutic use ; Female ; Hemorrhage ; Heparin/therapeutic use ; Humans ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 80238

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz